(1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((S)-1-(1H-imidazol-1-yl)propan-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-2-methylenecyclohexane-1,3-diol

ID: ALA3360784

PubChem CID: 101563630

Max Phase: Preclinical

Molecular Formula: C25H36N2O2

Molecular Weight: 396.58

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1[C@H](O)CC(=C/C=C2\CCC[C@]3(C)[C@@H]([C@H](C)Cn4ccnc4)CC[C@@H]23)C[C@H]1O

Standard InChI:  InChI=1S/C25H36N2O2/c1-17(15-27-12-11-26-16-27)21-8-9-22-20(5-4-10-25(21,22)3)7-6-19-13-23(28)18(2)24(29)14-19/h6-7,11-12,16-17,21-24,28-29H,2,4-5,8-10,13-15H2,1,3H3/b20-7+/t17-,21-,22+,23-,24-,25-/m1/s1

Standard InChI Key:  FHDAHQFLZOYWQM-QDYAWOJKSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   24.5577   -5.9041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5577   -6.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2703   -7.1356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9830   -6.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9830   -5.9041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2703   -5.4853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8431   -7.1407    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.6974   -7.1407    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.2703   -4.6603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9854   -4.2498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9854   -3.4247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9918   -1.7769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2750   -2.1862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2712   -3.0139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7051   -2.1912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7015   -3.0106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4798   -3.2701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9620   -2.6086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4856   -1.9429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6970   -3.8352    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   26.6970   -1.3641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7428   -1.1591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5507   -0.9919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1921   -0.5425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1015   -1.6086    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2809   -1.7248    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   25.2703   -7.9606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9280   -2.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6372   -2.8245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2539   -2.2737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.9232   -1.5223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  2  7  1  6
  4  8  1  1
  6  9  2  0
  9 10  1  0
 10 11  2  0
 11 16  1  0
 11 14  1  0
 15 12  1  0
 12 13  1  0
 13 14  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 15  1  0
 16 20  1  6
 15 21  1  1
 19 22  1  0
 22 23  1  0
 22 24  1  6
 23 25  1  0
 19 26  1  6
  3 27  2  0
 25 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 25  1  0
M  END

Associated Targets(Human)

CYP24A1 Tchem Cytochrome P450 24A1 (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 396.58Molecular Weight (Monoisotopic): 396.2777AlogP: 4.66#Rotatable Bonds: 4
Polar Surface Area: 58.28Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.53CX LogP: 3.22CX LogD: 3.18
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.73Np Likeness Score: 1.35

References

1. Ferla S, Aboraia AS, Brancale A, Pepper CJ, Zhu J, Ochalek JT, DeLuca HF, Simons C..  (2014)  Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation.,  57  (18): [PMID:25148392] [10.1021/jm5009314]
2. Bruno, Robert D RD and Njar, Vincent C O VC.  2007-08-01  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.  [PMID:17544277]
3. Taban, Ismail M IM, Zhu, Jinge J, DeLuca, Hector F HF and Simons, Claire C.  2017-08-01  Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides.  [PMID:28601511]

Source